Kent Armeson to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications Kent Armeson has written about Antineoplastic Agents, Immunological.
Connection Strength
0.213
-
Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma. BMC Cancer. 2020 Mar 17; 20(1):229.
Score: 0.167
-
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
Score: 0.046